menu

ReachMD

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

Rethinking Risk of Bilateral Oopherectomy With Hysterectomy

ReachMD Healthcare Image
Restart
Resume
Choose a format
Media formats available:
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.
Details
Presenters
Comments
  • Overview

    For many years, bilateral oopherectomy has been a routine part of hysterectomy. After a certain age, we reasoned that the role of the ovaries in helping women achieve hormonal balance was outweighed by the risks for ovarian cancer, thus offering women their best odds of long-term survival. Yet new evidence on the risks of routine bilateral oopherectomy challenges this conventional wisdom. Is it time we change our practice? Host Dr. Mark Nolan Hill examines the findings with Dr. William Parker, clinical professor of obstetrics and gynecology at the University of California, Los Angeles David Geffen School of Medicine, and a faculty member of the John Wayne Cancer Institute in Santa Monica, California. The lead author of a study published in Obstetrics and Gynecology, Dr. Parker also explores the mechanisms behind the potential risks investigated by his team, ranging from specific cancers to heart disease and all-cause mortality.

Facebook Comments

Recommended
Details
Presenters
Comments
  • Overview

    For many years, bilateral oopherectomy has been a routine part of hysterectomy. After a certain age, we reasoned that the role of the ovaries in helping women achieve hormonal balance was outweighed by the risks for ovarian cancer, thus offering women their best odds of long-term survival. Yet new evidence on the risks of routine bilateral oopherectomy challenges this conventional wisdom. Is it time we change our practice? Host Dr. Mark Nolan Hill examines the findings with Dr. William Parker, clinical professor of obstetrics and gynecology at the University of California, Los Angeles David Geffen School of Medicine, and a faculty member of the John Wayne Cancer Institute in Santa Monica, California. The lead author of a study published in Obstetrics and Gynecology, Dr. Parker also explores the mechanisms behind the potential risks investigated by his team, ranging from specific cancers to heart disease and all-cause mortality.

Facebook Comments

Schedule25 Apr 2024